SCHEMBL27631908

SCHEMBL27631908

OOBc1cccc(Nc2nc(Nc3ccc4c(c3)OCCO4)ncc2F)c1

nearest known ligand 0.68

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SYK P43405 17/20 0.68
EGFR P00533 2/20 0.65
BTK Q06187 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL656865 0.89 SYK (0.68) SYKEGFRBTK
SCHEMBL31294168 0.85 SYK (0.79) SYKEGFR
SCHEMBL656467 0.85 SYK (0.79) SYKEGFR
SCHEMBL656182 0.85 SYK (0.74) SYKEGFR
SCHEMBL656609 0.84 SYK (0.70) SYKEGFR
SCHEMBL655465 0.83 SYK (0.73) SYKEGFR
SCHEMBL656636 0.83 SYK (0.68) SYKEGFRBTK
SCHEMBL655437 0.82 SYK (0.76) SYKEGFRBTK
SCHEMBL656301 0.81 SYK (0.69) SYKEGFRBTK
SCHEMBL654741 0.81 SYK (0.75) SYKEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 CN disclosed